Product Pathways - Cell Cycle / Checkpoint
Oncogene and Tumor Suppressor Antibody Sampler Kit #8678
|8678S||1 Kit (8 x 40 µl)||---||In Stock||---|
Already purchased this product? Write a Review.
|Kit Includes||Quantity||Applications||Reactivity||Homology†||MW (kDa)||Isotype|
|E-Cadherin (24E10) Rabbit mAb #3195||40 µl||W, IHC-P, IHC-F, IF-IC, F||H, M||B, Dg, Pg||135||Rabbit IgG|
|p53 (7F5) Rabbit mAb #2527||40 µl||W, IHC-P, IF-IC, F, ChIP||H, Mk||53||Rabbit IgG|
|Stathmin Antibody #3352||40 µl||W, IHC-P||H, M, R, Mk||19||Rabbit|
|BRCA1 Antibody #9010||40 µl||W, IP||H||220||Rabbit|
|Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb #4060||40 µl||W, IP, IHC-P, IHC-F, IF-IC, F||H, M, R, Hm, Mk, Dm, Z, B||C, X, Dg, Pg||60||Rabbit IgG|
|PTEN (138G6) Rabbit mAb #9559||40 µl||W, IP, IHC-P||H, M, R, Mk||54||Rabbit IgG|
|Phospho-Estrogen Receptor α (Ser167) (D1A3) Rabbit mAb #5587||40 µl||W||H||Mk||66||Rabbit IgG|
|HER2/ErbB2 (D8F12) XP® Rabbit mAb #4290||40 µl||W, IHC-P||H||M, R||185||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody #7074||100 µl||Goat|
†Species predicted to react based on 100% sequence homology.
Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin), IHC-F=Immunohistochemistry (Frozen), IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry, ChIP=Chromatin IP, IP=Immunoprecipitation
Reactivity Key: H=Human, M=Mouse, Mk=Monkey, R=Rat, Hm=Hamster, Dm=D. melanogaster, Z=Zebrafish, B=Bovine
Western blot analysis of extracts from 293 and COS cells using p53 (7F5) Rabbit mAb #2527.
Western blot analysis of extracts from various cell lines using E-Cadherin (24E10) Rabbit mAb #3195.
Western blot analysis of extracts from various cell lines using Stathmin Antibody #3352.
Western blot analysis of extracts from PC-3 cells, untreated (-) or LY294002/wortmannin-treated (+), and NIH/3T3 cells, serum-starved (-) or PDGF-treated (+), using Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb #4060 (upper) or Akt (pan) (C67E7) Rabbit mAb #4691 (lower).
Western blot analysis of extracts from SK-BR-3 and MCF7 cells using HER2/ErbB2 (D8F12) XP® Rabbit mAb #4290.
Western blot analysis of extracts from MCF7 cells, untreated (-) or treated with Estrodiol/EGF (100 nM each, together for 30 min; +) followed by calf intestinal phosphatase (CIP; +), using Phospho-Estrogen Receptor α (Ser167) (D1A3) Rabbit mAb #5587 (upper) or an estrogen receptor α mouse mAb (lower).
Western blot analysis of extracts from HeLa cells, untreated (-) and UV-treated (50 mJ/cm2, 30 min; +), using BRCA1 Antibody #9010.
The Oncogenes and Tumor Suppressor Antibody Sampler Kit offers an economical means of investigating proteins commonly involved in the biological pathways behind oncogenesis, tumor metastasis, and cancer pathology. The kit contains enough primary and secondary antibody to perform four western blot experiments with each antibody.
Specificity / Sensitivity
Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb recognizes endogenous levels of Akt only when phosphorylated at Ser473. BRCA1 Antibody recognizes endogenous levels of total BRCA1 protein. The antibody detects BRAC1 nuclear isoforms 1, 2, and 4, but not BRAC1 cytoplasmic isoforms 3 and 5, and does not detect BRCA2. E-Cadherin (24E10) Rabbit mAb recognizes endogenous levels of total E-cadherin protein. The antibody does not cross-react with related family members, such as N-cadherin. Phospho-Estrogen Receptor α (Ser167) (D1A3) Rabbit mAb recognizes endogeneous levels of ERα only when phosphorylated at Ser167. The antibody cross reacts with a nonspecific band at around 77 kDa. HER2/ErbB2 (D8F12) XP® Rabbit mAb recognizes endogenous levels of total HER2/ErbB2 protein. p53 (7F5) Rabbit mAb detects endogenous levels of total p53 protein. The antibody binding has been mapped to the amino terminus region of human p53 protein. PTEN (138G6) Rabbit mAb recognizes endogenous levels of total PTEN protein. Stathmin Antibody recognizes endogenous levels of total stathmin protein. The antibody does not cross-react with related proteins, such as SCG10, SCLIP, and RB3.
Source / Purification
Phospho-specific monoclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser473 of human Akt protein or Ser167 of human estrogen receptor α protein. Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro780 of human E-cadherin protein, residues near the amino terminus of human HER2/ErbB2 protein, the carboxy terminus of human PTEN protein, or with a full-length human p53 fusion protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding the amino terminus of human BRCA1 protein or residues surrounding Ser38 of human stathmin protein. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.
Oncogenesis is a multistep process leading to sequential alterations in several oncogenes, tumor-suppressor genes, and microRNA genes (1,2). These alterations often disrupt the expression, function, and/or activity of proteins regulating cell growth and programmed cell death. Many of the molecular mechanisms and biological pathways driving oncogenesis and cancer pathology have been identified. The signal transduction pathways regulating apoptosis, cell-cycle progression, cell adhesion, cell migration, and DNA damage responses are often disrupted. HER2/ErbB2 (3), E-Cadherin (4), p53 (5,6), Stathmin (7), BRCA1 (8,9), Akt (10), PTEN (11), and Estrogen Receptor α (12) function in many of these pathways.
- Berger, A.H. et al. (2011) Nature 476, 163-9.
- Peltomäki, P. (2012) Exp Cell Res 318, 299-310.
- Dittadi, R. and Gion, M. (2000) J Natl Cancer Inst 92, 1443-4.
- Hazan, R.B. et al. (2004) Ann N Y Acad Sci 1014, 155-63.
- Rahman, N. and Stratton, M.R. (1998) Annu Rev Genet 32, 95-121.
- Freed-Pastor, W.A. and Prives, C. (2012) Genes Dev 26, 1268-86.
- Belletti, B. and Baldassarre, G. (2011) Expert Opin Ther Targets 15, 1249-66.
- Gayther, S.A. et al. (1999) Am J Hum Genet 65, 1021-9.
- Scully, R. and Livingston, D.M. (2000) Nature 408, 429-32.
- Jazirehi, A.R. et al. (2012) Am J Cancer Res 2, 178-91.
- Saal, L.H. et al. (2008) Nat Genet 40, 102-7.
- Pópulo, H. et al. (2012) Int J Mol Sci 13, 1886-918.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
* Product-specific protocol.
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
Select rabbit monoclonal antibodies are developed, validated, and produced at CST using in part technology under license (granting certain rights including those under U.S. Patents No. 5,675,063 and in some instances 7,429,487) from Epitomics, Inc.